The much-anticipated guideline is now available for RQA members.
More information
Mind the gap - connected by quality. 4th - 6th November 2026, London.
More information
RQA membership is a great way to connect with your QA colleagues.
More information
Join the community - networking, discussion and more. Open to all.
More information
Could you write an interesting article for the RQA community?
More information31st July 2026
Summary: This month's MHRA News showcases a broad range of regulatory and policy developments. Highlights include publication of the MHRA's 2025–26 Annual Report, a public consultation on a new Rare Disease Therapies Regulatory Framework, guidance on the use of ambient voice technologies in the NHS, and the launch of the London Region I AI Regulatory Sandbox. The newsletter also covers improvements to clinical trial approvals and study set-up, updates to the International Recognition Procedure and medical device clinical investigation guidance, alongside initiatives to strengthen medicines security, support real-world evidence generation, advance space-enabled pharmaceutical research and improve access to life-saving plasma-derived medicines.
Link: https://content.govdelivery.com/accounts/UKMHRA/bulletins/42273b9